|
Match
|
Document |
Document Title |
|
|
6780440 |
Herbal compositions and methods for diabetes and weight loss management
Herbal compositions and methods suitable for weight loss management and for treating diabetes are disclosed. The compositions comprise Ferula hermonis or an extract thereof, or Ferula hermonis ...
|
|
|
6780437 |
Coated potassium chloride granules and tablets
This invention provides extended release potassium chloride granules consisting essentially of potassium chloride crystals having a mesh size of about 20-60 mesh that are coated only with...
|
|
|
6780438 |
Dietary supplement comprising colostrum and citrus pectin
A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing....
|
|
|
6773722 |
Process for the preparation of granular and porous sucralfate dry gel
Sucralfate gel in the dry state in porous granular form having a particle-size distribution of between 100 and 1000 μm, an apparent density of the powder bed of between 0.7 and 0.9 g/ml, a...
|
|
|
6773725 |
Composition for increasing preservative capability and promoting the growth of living organism and a preparing method thereof
The present invention relates a composition promoting the growth, and increasing preservative capability of human body, animals and plants. The composition of the present invention maximizes...
|
|
|
6773720 |
Mesalazine controlled release oral pharmaceutical compositions
Controlled-release oral pharmaceutical compositions containing as active ingredient 5-amino-salicylic acid, comprising: a) an inner lipophilic matrix consisting of substances with a melting point...
|
|
|
6770296 |
Process for producing coated preparation and its use
There is provide a novel process for producing a coated preparation composed of a hydrophilic core material coated with a coat material selected from hydrophobic hot-melt lipid to control...
|
|
|
6770297 |
Controlled release delivery system of solid dosage form
This invention relates to a controlled release delivery system of solid dosage form with a plurality of controls on the release of the active ingredient or ingredients.
|
|
|
6767556 |
Pharmaceutical compositions comprising moexipril magnesium
Stable solid compositions comprising moxeipril magnesium can be made using moexipril or an acid addition salt thereof, by reacting the moxeipril or acid addition salt with an alkaline magnesium...
|
|
|
6767550 |
Hydroxyapatite based drug delivery implant for cancer treatment
A hydroxyapatite based bioresorbable material is incorporated with anti-cancer agents to form an implant used for treatment against cancer. Sustained release of the anti-cancer agents may be...
|
|
|
6764694 |
Stable formulations of ACE inhibitors, and methods for preparation thereof
The present invention provides stable formulations of ACE inhibitors, especially enalapril maleate, that can be manufactured in a time efficient, cost effective manner. Such formulations can be...
|
|
|
6764695 |
Tablet and process for producing tablets
A tablet including active substance affected by lubricant, wherein the tablet is comprised of compressed mixture of active substance and adjuvant except for lubricant, and lubricant exists only on...
|
|
|
6761903 |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
The present invention relates to pharmaceutical compositions and methods for improved solubilization of triglycerides and improved delivery of therapeutic agents. Compositions of the present...
|
|
|
6761905 |
Process for the preparation of direct tabletting formulations and aids
A thermal adhesion granulation process for preparing direct tabletting formulations or aids is disclosed. The process comprises the step of subjecting all or part of a mixture comprising: A) from...
|
|
|
6761898 |
Combination composition in the form of nutritional supplement or pharmaceutical composition for the prevention and therapeutical treatment of degenerative or inflammatory articular disorders
The present invention relates to a composition, which contains L-carnitine or alkanoyl-L-carnitine, and a glucosaminoglycan or a constituent thereof, suitable for the prevention of articular...
|
|
|
6761907 |
Coated dosage units
Dosage units, such as tablet cores and granules, containing a composition comprising a steroid having two hydrogen atoms at position 3 of the steroid skeleton, are coated. While a conventional...
|
|
|
6761904 |
Pharmaceutical kit comprising midodrine as active drug substance
The invention provides a novel pharmaceutical kit comprising a controlled release pharmaceutical compositions for oral use containing midodrine and/or its active metabolite desglymidodrine. The...
|
|
|
6761908 |
Collagen preparation for the controlled release of active substances
A collagen preparation for the controlled release of active substances is characterized in that it has mixtures of acid-insoluble collagens with different molecular weight distributions.
|
|
|
6759055 |
Dietary supplements for improving kidney function
Compositions comprising a plurality of yeast cells, wherein said plurality of yeast cells are characterized by their ability to improve kidney functions (e.g., restoring urine secretion and/or...
|
|
|
6759053 |
S(&plus ) Desmethylselegiline and its use to treat ADHD
The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of...
|
|
|
6756050 |
Dietary supplements for improving memory
Compositions comprising a plurality of yeast cells, wherein said plurality of yeast cells have been cultured in the presence of an alternating electric field having a specific frequency and a...
|
|
|
6756056 |
Treatment of Parkinson's disease and related disorders by novel formulations of the combination carbidopa-levodopa
An oral antiparkinson drug delivery system consisting of carbidopa and levodopa in immediate and sustained release compartments provides a significant clinical advantage over currently available...
|
|
|
6753012 |
Method for coating pharmaceutical dosage forms
The invention provides a process for coating a branded pharmaceutical dosage form for the purpose of covering any embossed or printed matter or any colored coating by the application of an amount...
|
|
|
6753009 |
Soft tablet containing high molecular weight polyethylene oxide
The invention relates to an immediate release tablet capable of being chewed or disintegrated in the oral cavity, which comprises a pharmaceutically active ingredient, and a matrix comprising...
|
|
|
6752997 |
Process for preparing non-hygroscopic sodium valproate composition
The invention is directed to non-hygroscopic oral pharmaceutical compositions of a salt of valproic acid, and processes for preparing the compositions. The non-hygroscopic pharmaceutical...
|
|
|
6753008 |
Dietary supplements beneficial for the liver
Compositions comprising a plurality of yeast cells, wherein said plurality of yeast cells are characterized by their ability to normalize the serum level of GPT, AP and/or LDH-5 in a mammal, said...
|
|
|
6750249 |
Controlled release oral preparations of esculetin and its derivatives
The present invention relates to an oral preparation of esculetin with controlled release. The oral preparation of esculetin with controlled release of the present invention comprises a gel-forming...
|
|
|
6750331 |
Oligosaccharide-supplying compositions
The present invention provides an oligosaccharide-supplying composition which contains 10 to 80% by weight of oligosaccharide, 0.3 to 10% by weight of a foaming component and 0.9 to 30% by weight...
|
|
|
6749867 |
Delivery system for omeprazole and its salts
The present invention provides a time-release dosage form for delivering an acid-labile pharmaceutical, such as omeprazole, into the upper portion of the gastrointestinal tract downstream of the...
|
|
|
6746678 |
Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
This invention defines a novel method for treatment of several neurological diseases and pathophysiologically related symptomology, said diseases including peripheral neuropathies, secondary...
|
|
|
6746692 |
Modified release pharmaceutical formulation comprising amoxycillin
Bacterial infections may be treated using a high dosage regimen of amoxycillin and potassium clavulanate. Preferably, the dosage is provided by a bilayer tablet.
|
|
|
6743445 |
Low temperature coatings
A method of coating an active material is provided. The method comprises contacting an active material with a film-forming composition comprising an aqueous dispersion of an amylose-alcohol...
|
|
|
6743443 |
Tablets immediately disintegrating in the oral cavity
The present invention provides an intraoral quickly disintegrating tablet containing a phosphodiesterase inhibitor having an effect of improving the erectile dysfunction and a method for...
|
|
|
6740340 |
Pharmaceutical tablets comprising an NSAID and a prostaglandin
A pharmaceutical tablet which incorporates two smaller tablets, one of which comprises an NSAID and the other of which comprises misoprostol.
|
|
|
6740339 |
Quickly disintegrating solid preparations
Quickly disintegrating solid preparations which contain: a) an active ingredient; b) D-mannitol having an average particle size of 30 μm to 300 μm; c) a disintegrating agent; and d) celluloses.
|
|
|
6740338 |
Reduced form of Cenzyme Q in high bioavailability stable oral dosage form
The present invention relates to a reduced form of Coenzyme Q also known as ubiquinol in oral dosage form such as a gelatin capsule, preferably a soft gelatin capsule. Compositions according to the...
|
|
|
6740334 |
Bone resorption suppressing agent
A highly safe bone resorption suppressing agents, which can be used as medicines or admixed to food products or feeds, is produced. Milk-derived basic cystatins and/or milk-derived basic cystatin...
|
|
|
6737087 |
Composition containing Asiasari Radix extracts for protecting brain cells and improving memory
The present invention discloses that fractions of Asiasari Radix extract have the ability to induce neuroprotection against AMPA (-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-induced...
|
|
|
6733779 |
Method of treating benign prostatic hyperplasia and other benign prostate conditions
Methods of treatment of benign prostatic hyperplasia and reduction of the level of the prostate specific antigen (PSA) of benign prostate conditions are disclosed. The treatment method includes an...
|
|
|
6733782 |
Core tablet for controlled release of gliclazide after oral administration
The invention relates to a matrix tablet for the prolonged release of gliclazide which ensures continuous and consistent release of the active ingredient after administration by the oral route, the...
|
|
|
6733749 |
Throat lozenges for the treatment of Hemosphilus influenza
A lozenge for the treatment of Hemophilus influenzae infections of the mouth throat and nasal passage is disclosed which comprises a lytic enzyme composition specific for Hemophilus influenzae ,...
|
|
|
6733784 |
Coated, platform-generating tablet
An expanding tablet is described comprising a drug release controlling membrane material. After swallowing, the tablet hydrates and expands such that the membrane ruptures to directly expose some...
|
|
|
6733780 |
Direct compression polymer tablet core
The present invention provides a tablet core which comprises at least about 95% by weight of an aliphatic amine polymer. The invention also provides a method of producing a tablet core comprising...
|
|
|
6733781 |
Fast dissolving tablet
The present invention relates to processes for the preparation of tablets which dissolve rapidly in the mouth and provide an excellent mouthfeel. The tablets of the invention comprise a compound...
|
|
|
6733789 |
Multiparticulate bisoprolol formulation
A multiparticulate bisoprolol formulation for once-daily oral administration, each particle of which comprises a core of bisoprolol or a pharmaceutically acceptable salt thereof surrounded by a...
|
|
|
6730319 |
Pharmaceutical compositions having depressed melting points
The present invention relates to pharmaceutical compositions that contain a solid pharmaceutically active compound having a melting point ≧37° C. and a fatty acid or a fatty acid salt or a...
|
|
|
6730321 |
Press coated, pulsatile drug delivery system suitable for oral administration
A press-coated tablet suitable for oral administration, comprising an immediate-release compartment comprising a compressed blend of an active agent. The immediate-release compartment has a...
|
|
|
6730320 |
Tetracycline antibiotic product, use and formulation thereof
An antibiotic product, in particular a tetracycline, such as doxycycline, is comprised of at least three dosages forms, each of which has a different release profile, with the C max for the...
|
|
|
6726927 |
Preparation of enteric pharmaceutical dosage forms for omerprazole and lansoprazole
The present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing Omeprazole or Lansoprazole, to a formulation and a method for the manufacture of such...
|
|
|
6726929 |
Pharmaceutical mixture comprising a profen
A pharmaceutical mixture comprising a profen is described which has a profen content of over 85% and contains up to 1% of a nonionic surfactant having an HLB of ≧9 and also a customary...
|